Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07313358Not Yet Recruiting

10119473 -VIROMARKERS HDV Biomarkers Study

Role: collaborator

NCT05531773Recruiting

Post COVID-19 Condition

Role: lead

NCT05534009Recruiting

Health Care Workers Cohort Study in the EuCARE Project (EuCARE-HCW)

Role: lead

NCT06127290Recruiting

HIV Resistance, Molecular Epidemiology and New Treatment Strategies in the Eastern European Region and in Russia

Role: lead

NCT05396040Not ApplicableCompleted

School Studies Within the EuCARE Horizon Europe Research Project (EuCARE-SCHOOLS)

Role: lead

NCT05463380Recruiting

Hospitalised COVID-19 Patients Cohort Study in the EuCARE Project

Role: lead

All 6 trials loaded